title: Liposome technology for industrial purposes.
abstract: Liposomes, spherical vesicles consisting of one or more phospholipid bilayers, were first described in the mid 60s by Bangham and coworkers. Since then, liposomes have made their way to the market. Today, numerous lab scale but only a few large-scale techniques are available. However, a lot of these methods have serious limitations in terms of entrapment of sensitive molecules due to their exposure to mechanical and/or chemical stress. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability. An additional point of view was taken to regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
authors.affiliation: Polymun Scientific Immunbiologische Forschung GmbH, Nu β dorfer Lände 11, 1190 Vienna, Austria.
authors.forename: Andreas
authors.initials: A
authors.lastname: Wagner
authors.forename: Karola
authors.initials: K
authors.lastname: Vorauer-Uhl